Pfizer Inc.
Albert Bourla (Chairman & CEO) reports PFE insider transactions
AI-generated summary
Albert Bourla, Chairman & CEO, Director of Pfizer Inc., received a grant of 20 Phantom Stock Units SSP at $30.52 per share on October 30, 2026. Following this transaction, the reporting person directly held 783,828 shares. This acquisition was not made under a Rule 10b5-1 trading plan.
Key facts
- Insider
- Albert Bourla · Chairman & CEO, Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 30, 2026 | A · grantPhantom Stock Units SSPFootnotes F1, F2 | +20 | $30.52 | $610.40 | 783,828 | Direct |
Footnotes
- F1 Each unit represents one phantom share of common stock.
- F2 These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
More PFE filings
- 10-Q
Filed Nov 3, 2026
- 8-K
Filed Nov 3, 2026
- 4
Filed Oct 16, 2026
- SC 13G
Filed Oct 16, 2026
- 4
Filed Oct 14, 2026
- 4
Filed Oct 1, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.